Analyst Ratings for Zenas Biopharma (ZBIO)
ZBIO Rating Summary
ZBIO Price Target Summary
- Highest: $55.00 (Guggenheim)
- Lowest: $32.00 (Morgan Stanley)
- Average: $45.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.40 (+69%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$45.40 (+69%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/19/2026 | Morgan Stanley | Chris Yu | New Coverage | Equalweight (N/A) |
32.00 (N/A) |
24.84 (26.87) |
8.17% | Details |
| 3/20/2025 | Wedbush | Martin Fan | New Coverage | Outperform (N/A) |
35.00 (N/A) |
8.25 (26.87) |
225.7% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
